BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2019
View Archived Issues
Low-coverage genome sequencing gives answers in infertility
Read More
Measles vaccine far more protective than realized
Read More
AGTC announces second ophthalmology program, reports promising preclinical data on dual AAV
Read More
CD205-targeting antibody-drug conjugate shows selective antitumor efficacy in preclinical studies
Read More
FDA clears IND application for phase II study of VB-111 in surgically accessible rGBM
Read More
Hoth Therapeutics initiates confirmatory study of the AEA-loaded-Z pods in models of lupus
Read More
New milestones announced for hematology product candidate AXA-4010
Read More
Phase III study of Treakisym in DLBCL achieves primary endpoint of ORR
Read More
Vaccibody announces preliminary phase I/IIa data for VB10.NEO neoantigen cancer vaccine
Read More
Early clinical data presented for AGIL-AADC gene therapy in children with AADC deficiency
Read More
Adagene presents first-in-human data for ADG-106
Read More
ABSK-041, a highly potent and orally available small-molecule PD-L1 antagonist
Read More
Sanofi Pasteur presents preclinical data for ZIKV vaccine ZPIV-SP
Read More
Schizophrenia biomarker can be detected in human hair
Read More
Boehringer Ingelheim reports data on new SOS1-KRAS interaction inhibitors for cancer
Read More
New phase I trial explores BI-1701963 in KRAS-mutated advanced or metastatic solid tumors
Read More
Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia
Read More
Lilly opens phase I study of LY-3435151 in advanced solid tumors
Read More
Bristol-Myers Squibb presents new MGAT2 inhibitors
Read More
U.K. researchers patent BCL-6 inhibitors
Read More
Thomas Helledays Stiftelse foer Medicinsk Forskning divulges MTHFD2 inhibitors
Read More
VTCN1 gene linked to schizophrenia in Chinese families
Read More
Chinese researchers present new p300 HAT inhibitors
Read More
Hungarian scientists patent myosin-2 ATPase activity inhibitors
Read More
ObsEva to discontinue nolasiban IVF program after phase III trial misses primary endpoint
Read More
CARB-X grant supports Techulon's development of new class of antimicrobial
Read More
